SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Taki K, Hirahara K, Tomita S, Totoki T. Therapeutic Research 1995; 16(4): 521-529.

Copyright

(Copyright © 1995)

DOI

unavailable

PMID

unavailable

Abstract

A 54-year-old man was admitted 3 hours after ingesting about 20 ml of paraquat solution (Glamoxon S®), and a 36-year-old man was admitted 12 hours after ingesting 20-30 ml of paraquat solution (Glamoxon S®). According to the Proudfoot survival curve, RI value and Sawada's SIPP, one of these cases was severe, but the other was not. Both cases recovered without developing pulmonary fibrosis, though PIIIP, PMN elastase, BUN, creatinine and β2-macroglobulin increased and Paraquat-induced interstitial pneumonia was observed. Therefore, in addition to aggressive therapy with ulinastatin, corticosteroid and other agents, local therapy using inspiration of ulinastatin should be considered in patients who show progressive deterioration in respiratory function.


Language: en

Keywords

adult; human; male; case report; suicide attempt; glutathione; paraquat; article; corticosteroid; lung function; intravenous drug administration; methylprednisolone; paraquat poisoning; interstitial pneumonia; lung fibrosis; betamethasone; lung insufficiency; inspiration of ulinastatin; local therapy; paraquat-induced interstitial pneumonia; ringer lactate solution; ulinastatin; ulinastatin therapy

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print